Pathway Labs News

Latest Pathway Labs news, funding rounds and robotics & AI coverage. $8.5M raised. 1 article tracked by The Robotics Media.

About Pathway Labs

Pathway Labs builds AI that helps clinicians catch heart disease earlier. Founded by Dr. Pierre Elias and cardiac AI researchers from Columbia University and NewYork-Presbyterian, its EchoNext tool reads routine 12-lead ECGs to flag six types of structural heart disease. The company raised an $8.5 million seed round led by AlleyCorp and Breyer Capital in June 2026.

Key facts

• Headquarters: New York, New York, United States
• Country: United States
• Founded: 2025
• Sectors: Medical Imaging, Digital Health
• Website: https://pathwaylabs.com

Products by Pathway Labs

• EchoNext — EchoNext is the world's first FDA-cleared AI detection tool that reads standard 12-lead electrocardiograms to flag six types of structural heart disease, includ...

Funding rounds

• Seed — $8.5M — 2026 — led by AlleyCorp

Latest Pathway Labs news

• EchoNext Wins First FDA Nod for Multicondition Heart AI on ECGs — Pathway Labs' EchoNext has become the world's first FDA-cleared AI to detect six types of structural heart disease from standard 12-lead ECGs, launchi...